121 related articles for article (PubMed ID: 27829332)
1. In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid.
Carlier J; Diao X; Wohlfarth A; Scheidweiler K; Huestis MA
Curr Neuropharmacol; 2016 Nov; ():. PubMed ID: 27829332
[TBL] [Abstract][Full Text] [Related]
2.
Carlier J; Diao X; Wohlfarth A; Scheidweiler K; Huestis MA
Curr Neuropharmacol; 2017 Jul; 15(5):682-691. PubMed ID: 29403341
[TBL] [Abstract][Full Text] [Related]
3. UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and α-PVT, by human liver microsome.
Takayama T; Suzuki M; Todoroki K; Inoue K; Min JZ; Kikura-Hanajiri R; Goda Y; Toyo'oka T
Biomed Chromatogr; 2014 Jun; 28(6):831-8. PubMed ID: 24861751
[TBL] [Abstract][Full Text] [Related]
4. Metabolic profiling of synthetic cannabinoid 5F-ADB and identification of metabolites in authentic human blood samples via human liver microsome incubation and ultra-high-performance liquid chromatography/high-resolution mass spectrometry.
Presley BC; Castaneto MS; Logan BK; Jansen-Varnum SA
Rapid Commun Mass Spectrom; 2020 Nov; 34(22):e8908. PubMed ID: 32710798
[TBL] [Abstract][Full Text] [Related]
5. Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications.
Lobato-Freitas C; Brito-da-Costa AM; Dinis-Oliveira RJ; Carmo H; Carvalho F; Silva JP; Dias-da-Silva D
Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33669071
[TBL] [Abstract][Full Text] [Related]
6. UPLC-HR-MS/MS-based determination study on the metabolism of four synthetic cannabinoids, ADB-FUBICA, AB-FUBICA, AB-BICA and ADB-BICA, by human liver microsomes.
Li J; Liu C; Li T; Hua Z
Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 28992356
[TBL] [Abstract][Full Text] [Related]
7. Four types of cannabimimetic indazole and indole derivatives, ADB-BINACA, AB-FUBICA, ADB-FUBICA, and AB-BICA, identified as new psychoactive substances.
Qian Z; Hua Z; Liu C; Jia W
Forensic Toxicol; 2016; 34():133-143. PubMed ID: 26793280
[TBL] [Abstract][Full Text] [Related]
8. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
Yeter O; Ozturk YE
Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
[TBL] [Abstract][Full Text] [Related]
9. Urinary Metabolite Biomarkers for the Detection of Synthetic Cannabinoid ADB-BUTINACA Abuse.
Sia CH; Wang Z; Goh EML; Tan YL; Fong CY; Moy HY; Chan ECY
Clin Chem; 2021 Nov; 67(11):1534-1544. PubMed ID: 34387654
[TBL] [Abstract][Full Text] [Related]
10. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. Temporary Scheduling Order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2017 Apr; 82(67):17119-24. PubMed ID: 28425681
[TBL] [Abstract][Full Text] [Related]
11. The metabolic profile of the synthetic cannabinoid receptor agonist ADB-HEXINACA using human hepatocytes, LC-QTOF-MS and synthesized reference standards.
Baginski SR; Rautio T; Nisbet LA; Lindbom K; Wu X; Dahlén J; McKenzie C; Gréen H
J Anal Toxicol; 2023 Dec; 47(9):826-834. PubMed ID: 37747838
[TBL] [Abstract][Full Text] [Related]
12. The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisons.
Kronstrand R; Norman C; Vikingsson S; Biemans A; Valencia Crespo B; Edwards D; Fletcher D; Gilbert N; Persson M; Reid R; Semenova O; Al Teneiji F; Wu X; Dahlén J; NicDaéid N; Tarbah F; Sutcliffe OB; McKenzie C; Gréen H
Drug Test Anal; 2022 Apr; 14(4):634-652. PubMed ID: 34811926
[TBL] [Abstract][Full Text] [Related]
13. Fatal intoxication of a regular drug user following N-ethyl-hexedrone and ADB-FUBINACA consumption.
Kovács K; Kereszty É; Berkecz R; Tiszlavicz L; Sija É; Körmöczi T; Jenei N; Révész-Schmehl H; Institóris L
J Forensic Leg Med; 2019 Jul; 65():92-100. PubMed ID: 31128567
[TBL] [Abstract][Full Text] [Related]
14. Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection.
Carlier J; Diao X; Huestis MA
J Pharm Biomed Anal; 2018 Aug; 157():27-35. PubMed ID: 29754040
[TBL] [Abstract][Full Text] [Related]
15. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB- CHMICA and MDMB-FUBINACA) Into Schedule I. Notice of Intent.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 Dec; 81(245):93595-9. PubMed ID: 28068047
[TBL] [Abstract][Full Text] [Related]
16. A Systematic Study of the In Vitro Pharmacokinetics and Estimated Human In Vivo Clearance of Indole and Indazole-3-Carboxamide Synthetic Cannabinoid Receptor Agonists Detected on the Illicit Drug Market.
Brandon AM; Antonides LH; Riley J; Epemolu O; McKeown DA; Read KD; McKenzie C
Molecules; 2021 Mar; 26(5):. PubMed ID: 33807614
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA.
Banister SD; Moir M; Stuart J; Kevin RC; Wood KE; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Glass M; Connor M; McGregor IS; Kassiou M
ACS Chem Neurosci; 2015 Sep; 6(9):1546-59. PubMed ID: 26134475
[TBL] [Abstract][Full Text] [Related]
18. Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes.
Carlier J; Diao X; Sempio C; Huestis MA
AAPS J; 2017 Mar; 19(2):568-577. PubMed ID: 28070717
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of ADB-FUBIATA in zebrafish and pooled human liver microsomes investigated by liquid chromatography-high-resolution mass spectrometry.
Liu X; Tang Y; Xu L; Liu W; Xiang P; Hang T; Yan H
Rapid Commun Mass Spectrom; 2024 May; 38(9):e9730. PubMed ID: 38456249
[TBL] [Abstract][Full Text] [Related]
20. [Determination of four amide synthetic cannabinoid isomers by ultra-high performance liquid chromatography-high resolution mass spectrometry].
Tang R; Wang J; Xiao T; Qin S; Jie Z; Zhang A
Se Pu; 2024 Jan; 42(1):84-91. PubMed ID: 38197209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
